Pretreament nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

Journal of Clinical Oncology

Volumn 18, Issue 19, 2000, Pages 3352-3359

  Kattan, Michael W ^a   Zelefsky, Michael J ^a   Kupelian, Patrick A ^a   Scardino, Peter T ^a   Fuks, Zvi ^a   Leibel, Steven A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RECURRENCE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; ADJUVANT THERAPY; BLOOD; DISEASE FREE SURVIVAL; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK;

EID: 0034287457     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.19.3352     Document Type: Article

References (36)

1. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
2. The palpable nodule of prostatic cancer: Results 15 years after radical excision
3. Histologic grading and clinical staging of prostatic carcinoma
4. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
5. Combination of PSA, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer: A multi-institutional update
6. Validation of the Partin tables for predicting pathologic stage of clinically confined prostate cancer
7. Evaluation of a nomogram for predicting pathological stage of men with clinically localized prostate cancer
8. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
9. A postoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
10. Validation of a nomogram for predicting disease recurrence following radical prostatectomy for clinically localized prostate cancer
11. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
12. The T classification of clinically localized prostate cancer: An appraisal based on disease outcome after radiation therapy
13. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
14. Radiation therapy for clinically localized prostate cancer
15. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
16. A predictive model for prostate cancer
17. Identification of intermediate-risk prostate cancer patients treated with radical radiotherapy suitable for neoadjuvant hormone studies
18. Prognostic factors for clinically localized prostate carcinoma
19. An enhanced prognostic system for clinically localized carcinoma of the prostate
20. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions
21. Regression models and life tables
22. Design. S-Plus function for biostatistical/epidemiologic modeling, testing, estimation, validation, graphics, prediction
23. The biological basis and clinical application of three-dimensional conformal extemal beam radiation therapy in carcinoma of the prostate
24. Consensus statement: Guidelines for PSA following radiation therapy
25. Experiments to determine whether recursive partitioning (CART) or an artificial neural network overcomes theoretical limitations of Cox proportional hazards regression
26. Survnnet: Neural network model for survival models
27. Rpart: Recursive partitioning and regression trees
28. Regression trees for censored data
29. Polychotomous regression
30. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
31. The predictive accuracy of computer-based classification decision techniques: A review and research directions
32. Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy
33. The SUPPORT prognostic model: Objective estimates of survival for seriously ill hospitalized adults